Dr. Vinay Prasad drew criticism for overriding career scientists and rejecting drugs by companies seeking agency approval.
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But ...
The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials vowing to ...
Hosted on MSN
Flakka, the zombie drug: overdoses and effects
A look into Flakka, a synthetic drug that appeared in Florida. Sensational news reports and viral videos led to people comparing its effects to a zombie outbreak. The moment Trump found out the ...
Dear Doctors: I understand that there is treatment for the beginning stages of Alzheimer’s disease that can stave off serious decline. There are also new tests to determine if a person is in the ...
There is a new hope for people with spinal cord injuries. Doctors are using an experimental, easy to deliver drug, with surprising results. A Chicago are a patient who got the drug says it’s nothing ...
Joe Walsh is a senior editor for digital politics at CBS News. Joe previously covered breaking news for Forbes and local news in Boston. The Trump administration launched its new TrumpRx prescription ...
Bangor University provides funding as a member of The Conversation UK. For nearly three decades, decisions about which medicines the NHS pays for have not been made by ministers, but by the National ...
SAVANNAH, Ga. – When it comes to the war on illegal drugs, the Atlanta Drug Enforcement Administration is seeing some positive results while at the same time discovering new and, in some cases, ...
Zanzalintinib plus Tecentriq showed improved survival in metastatic colorectal cancer patients compared to Stivarga in the STELLAR-303 trial. The FDA accepted the new drug application for this ...
NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results